ATE133407T1 - Neue arylalkanoylaminderivate und diese enthaltendes arzneimittel - Google Patents

Neue arylalkanoylaminderivate und diese enthaltendes arzneimittel

Info

Publication number
ATE133407T1
ATE133407T1 AT91910447T AT91910447T ATE133407T1 AT E133407 T1 ATE133407 T1 AT E133407T1 AT 91910447 T AT91910447 T AT 91910447T AT 91910447 T AT91910447 T AT 91910447T AT E133407 T1 ATE133407 T1 AT E133407T1
Authority
AT
Austria
Prior art keywords
alkanoylamine
derivatives
products containing
containing same
medicinal products
Prior art date
Application number
AT91910447T
Other languages
English (en)
Inventor
Akihiro Zeria Pharmac Co Okubo
Numagami Oaza Oshikiri Aza
Hiroyasu Zeria Pharma Nishioka
Lab - Aza Numagami Oaza O Res
Heihachiro Zeria Pharamc Arai
Yoshiaki Zeria Pharmac Tanaka
Hisayoshi Zeria Pharmac C Kato
Naoki Zeria Pharmac Co Nakata
Numigami Oaza Oshikiri Aza
Original Assignee
Zeria Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharm Co Ltd filed Critical Zeria Pharm Co Ltd
Application granted granted Critical
Publication of ATE133407T1 publication Critical patent/ATE133407T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT91910447T 1990-06-07 1991-06-07 Neue arylalkanoylaminderivate und diese enthaltendes arzneimittel ATE133407T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14728190 1990-06-07

Publications (1)

Publication Number Publication Date
ATE133407T1 true ATE133407T1 (de) 1996-02-15

Family

ID=15426662

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91910447T ATE133407T1 (de) 1990-06-07 1991-06-07 Neue arylalkanoylaminderivate und diese enthaltendes arzneimittel

Country Status (8)

Country Link
US (1) US5407950A (de)
EP (1) EP0536399B1 (de)
AT (1) ATE133407T1 (de)
AU (1) AU643300B2 (de)
CA (1) CA2084204A1 (de)
DE (1) DE69116692T2 (de)
DK (1) DK0536399T3 (de)
WO (1) WO1991018877A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0670309A1 (de) * 1992-11-20 1995-09-06 Japan Tobacco Inc. Verbindung mit prolye-endopeptidase inhibierender aktivität und ihre pharmazeutische verwendung
JP3810097B2 (ja) * 1993-01-15 2006-08-16 明治製菓株式会社 ピロリジン−2−イルカルボニル複素環式化合物誘導体
EP1161415B1 (de) 1999-03-15 2005-07-13 Axys Pharmaceuticals, Inc. N-cyanomethylamide als protease inhibitoren
IL156577A0 (en) 2000-12-22 2004-01-04 Axys Pharm Inc Selective cathepsin s inhibitors and pharmaceutical compositions containing the same
US7030116B2 (en) 2000-12-22 2006-04-18 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin inhibitors
WO2003024924A1 (en) 2001-09-14 2003-03-27 Aventis Pharmaceuticals Inc. Novel compounds and compositions as cathepsin inhibitors
RU2004117877A (ru) 2001-11-14 2006-01-10 Авентис Фармасьютикалз Инк. (Us) Олигопептиды и композиции, содержащие их, в качестве ингибиторов катепсина s
FI20030014A0 (fi) * 2003-01-03 2003-01-03 Orion Corp Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä
ATE462432T1 (de) 2003-05-05 2010-04-15 Probiodrug Ag Glutaminylcyclase-hemmer
JP2007509898A (ja) 2003-11-03 2007-04-19 プロビオドルグ エージー 神経障害治療に有用な組合せ
KR101099206B1 (ko) 2004-02-05 2011-12-27 프로비오드룩 아게 신규한 글루타미닐 시클라제 저해제
EP1888562B1 (de) * 2005-04-22 2014-06-18 Alantos Pharmaceuticals Holding, Inc. Dipeptidylpeptidase-iv-hemmer
EP1760076A1 (de) 2005-09-02 2007-03-07 Ferring B.V. FAP Inhibitoren
JP5379692B2 (ja) 2006-11-09 2013-12-25 プロビオドルグ エージー 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての3−ヒドロキシ−1,5−ジヒドロ−ピロール−2−オン誘導体
EP2091948B1 (de) 2006-11-30 2012-04-18 Probiodrug AG Neue inhibitoren von glutaminylcyclase
CA2679446C (en) 2007-03-01 2016-05-17 Probiodrug Ag New use of glutaminyl cyclase inhibitors
US9656991B2 (en) 2007-04-18 2017-05-23 Probiodrug Ag Inhibitors of glutaminyl cyclase
US8524654B2 (en) * 2007-05-21 2013-09-03 The Uab Research Foundation Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation
BR112012008346B1 (pt) 2009-09-11 2021-12-21 Vivoryon Therapeutics N.V. Derivados heterocíclicos, seu processo de preparação, e composição farmacêutica
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
DK2545047T3 (da) 2010-03-10 2014-07-28 Probiodrug Ag Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
EP2560953B1 (de) 2010-04-21 2016-01-06 Probiodrug AG Hemmer der glutaminylzyklase
WO2012123563A1 (en) 2011-03-16 2012-09-20 Probiodrug Ag Benz imidazole derivatives as inhibitors of glutaminyl cyclase
DE102016116130A1 (de) * 2016-08-30 2018-03-01 Universität Bielefeld Verfahren zur Herstellung chiraler Aminonitrile
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3680578D1 (de) * 1985-04-16 1991-09-05 Suntory Ltd Dipeptid-derivate, verfahren zur herstellung, pharmazeutische zusammensetzungen und ihre anwendung.
JP2526084B2 (ja) * 1987-02-23 1996-08-21 小野薬品工業株式会社 新規なチアゾリジン誘導体
DE3712364A1 (de) * 1987-04-11 1988-10-27 Hoechst Ag Neue pyrrolidin-2-(1,3-dicarbonyl)-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung
US4857524A (en) * 1987-08-08 1989-08-15 Kissei Pharmaceutical Co., Ltd. Thiazolidine compounds and therapeutic method
JPH0670023B2 (ja) * 1987-08-08 1994-09-07 キッセイ薬品工業株式会社 チアゾリジン誘導体
JPH01250370A (ja) * 1987-12-23 1989-10-05 Zeria Pharmaceut Co Ltd 新規アミノ酸イミド誘導体、製法ならびに用途
US5053414A (en) * 1988-04-08 1991-10-01 Ono Pharmaceutical Co., Ltd. Heterocyclic compounds
US5212191A (en) * 1988-04-08 1993-05-18 Ono Pharmaceutical Co., Ltd. Heterocyclic compounds
CA2004028C (en) * 1988-12-08 1998-09-22 Motoki Torizuka Condensed benzene derivative
WO1990012005A1 (fr) * 1989-04-13 1990-10-18 Japan Tobacco Inc. Nouveaux derives aminoacides possedant une activite d'inhibiteur de la prolylendopeptidase

Also Published As

Publication number Publication date
AU643300B2 (en) 1993-11-11
DK0536399T3 (da) 1996-06-03
CA2084204A1 (en) 1991-12-08
DE69116692D1 (de) 1996-03-07
DE69116692T2 (de) 1996-09-05
US5407950A (en) 1995-04-18
AU7986691A (en) 1991-12-31
WO1991018877A1 (en) 1991-12-12
EP0536399B1 (de) 1996-01-24
EP0536399A1 (de) 1993-04-14
EP0536399A4 (en) 1993-04-21

Similar Documents

Publication Publication Date Title
ATE133407T1 (de) Neue arylalkanoylaminderivate und diese enthaltendes arzneimittel
ES2077138T3 (es) Derivados de aminocumarano, su produccion y su uso.
DE60140708D1 (de) Prolinderivative und deren Verwendung als Medikamente
DK131893A (da) 2-(Substitueret methyl)-4-(substitueret ethoxy)-5-(lavere alkyl)-pyridinforbindelser, farmaceutisk præparat, som indeholder sådanne samt anvendelse af en sådan forbindelse til fremstilling af et farmaceutisk præparat
EP0495776A4 (de) Stabilisierte komplexe bestehend aus stickoxyd/primäre amine zur verwendung als kardiovaskuläre wirkstoffe.
ATE181553T1 (de) Kondensierte thiazolverbindungen, ihre darstellung und ihre anwendung
HUT45983A (en) Process for production of derivatives of imidazolidinone
EP0191867A4 (de) Tricyclische oder tetracyclische verbindungen, deren herstellung und arzneimittel die diese enthalten.
TW347389B (en) Taxoids, their preparation and pharmaceutical compositions containing them
HUT64318A (en) Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance
DE69837334D1 (de) Heterozyclische verbindungen, ihr herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen
EP0318029A3 (en) Cyclic amine and pharmacological composition
ATE171704T1 (de) Optisch wirksame alkylendioxybenzolderivate und ihre verwendung als arzneimittel
ATE100102T1 (de) Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
IL100097A0 (en) Pyridyl derivatives,their preparation and pharmaceutical compositions containing them
IL93949A0 (en) Thioformamide derivatives and pharmaceutical compositions containing them
DE69330269D1 (de) Benzopyran-derivate, deren herstellung sowie diese als aktive bestandteile enthaltende arzneimittel
KR937000436A (ko) 신규 아릴알카노일아민 유도체 및 이를 함유하는 의약

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee